M. F. Lavoué

Antibody response against the Epstein‐Barr virus‐coded nuclear antigen2 (EBNA2) in different groups of individuals

J. M. Seigneurin, M. F. Lavoué, O. Genoulaz et al. · International Journal of Cancer · 1987 · 35 citations

Life Sciences, Immunology, Oncology +13

A comparison of the prognostic value of antibody‐dependent lymphocyte cytotoxicity and other ebv antibody assays in Chinese patients with nasopharyngeal carcinoma

S.H. Chan, Paul H. Levine, G de-Thé et al. · International Journal of Cancer · 1979 · 33 citations

Life Sciences, Infectious Diseases, Oncology +11

Epstein‐Barr viral serology in nasopharyngeal carcinoma patients in the USSR and Cuba, and its value for differential diagnosis of the disease

Vladimir Gurtsevitch, R. Ruiz, I. Plachov et al. · International Journal of Cancer · 1986 · 18 citations

Life Sciences, Immunology, Oncology +15

C620R mutation of the murine <i>ret</i> proto‐oncogene: Loss of function effect in homozygotes and possible gain of function effect in heterozygotes

Aldamaria Puliti, Elena Bonora, Cecilia Evangelisti et al. · International Journal of Cancer · 2007 · 15 citations · Full text

Medicine, Genetics, Molecular Genetics +17

SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients

Ling Yin, Véronique Ferrand, M. F. Lavoué et al. · Human Genetics · 1999 · 12 citations

Life Sciences, Genetics, Molecular Genetics +13